Results from an open-label extension study of etanercept in ankylosing spondylitis.
Davis
John
J
Webb
Allison
A
Lund
Steven
S
Sack
Kenneth
K
D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000009:adverse effects; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept